Atherosclerosis and Hyperlipidemia

APSC Consensus Recommendations on Dyslipidaemia
Category icon
APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh, Brian Ference, Stephen J Nicholls, et al

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
Category icon
The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, Alberto Silva-Obregón, et al

ACC 2021 Discussion: The STRENGTH Study
Category icon
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall

Inflammation and Cardiovascular Disease: The Future
Category icon
Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al

The Association Between Psoriasis and Cardiovascular Diseases
Category icon
The Association Between Psoriasis and Cardiovascular Diseases

Ahmed Zwain, Mohanad Aldiwani, Hussein Taqi,

Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease
Category icon
Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease

Anne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb,

Dyslipidaemia in the Real World
Category icon
Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk, et al

Anti-inflammatory Treatment and Cardiovascular Outcomes
Category icon
Anti-inflammatory Treatment and Cardiovascular Outcomes

Alberto Lorenzatti,

Bridging the Gap in a Rare Cause of Angina
Category icon
Bridging the Gap in a Rare Cause of Angina

Sumanth Khadke, Jovana Vidovic, Vinod Patel,

03/03/2021
Category icon
Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone, et al

A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
Category icon
A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess…

Morihiro Matsuda, Koji Hasegawa,

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
Category icon
Atherosclerotic CVD Risk and Advanced Lipid Testing

Charles Amir German, Michael D Shapiro,

Related Articles

Articles

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh, Brian Ference, Stephen J Nicholls,

Published:

Citation: European Cardiology Review 2021;16:e54.

DOI:

https://doi.org/10.15420/ecr.2021.36
The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, Alberto Silva-Obregón,

Published:

Citation: European Cardiology Review 2021;16:e28.

DOI:

https://doi.org/10.15420/ecr.2020.49
Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer,

Published:

Citation: European Cardiology Review 2021;16:e20.

DOI:

https://doi.org/10.15420/ecr.2020.50
The Association Between Psoriasis and Cardiovascular Diseases

Ahmed Zwain, Mohanad Aldiwani, Hussein Taqi,

Published:

Citation: European Cardiology Review 2021;16:e19.

DOI:

https://doi.org/10.15420/ecr.2020.15.R2